SV40 Contamination of the mRNA Shots - And Dr. Marik's Repurposed Drug PubMed Cancer Paper

Is it Time for Daily Repurposed Drugs to Prevent Cancer?

Reproduced with Permission

Dr. Paul Marik has finally published the most comprehensive article on the treatment of Cancer using repurposed drugs and metabolic interventions. This will be of enormous benefit for those of us suffering from Turbo Cancers related to the mRNA vaccines, especially now that we are seeing evidence of DNA Plasmid contamination related to SV40.

Dr. Buckhaults recently testified to the South Carolina Senate about the disturbing finding of DNA plasmids in mRNA vaccine vials at contamination concentrations greater than 100-fold more than the acceptable safety limit.

Dr. Buckhaults Testifies about Serious DNA Plasmid Contamination in mRNA Vaccines

Buckhaults’s findings replicated what a number of other research labs also found, and there is now little doubt as to its validity - the shots can produce DNA transfer that can not only cause cancer, but they can transmit to one’s offspring. This creates massive potential issues, and the FDA has responded by stating they do not believe this is a credible threat, against the voices of multiple experts.

SV40 is a promotor that facilitates the transfection or entry of plasmid DNA into a cell. Without SV40 gene therapy is not practically effective, but the presence of SV40 accelerates it by up to 200-fold.

In my opinion, the presence of these DNA fragment contaminants coupled with the SV40 promotor is a recipe for disaster, not only for causing cancer, alteration of the human genome, and a host of fertility issues, but for accelerated auto-immune disease, and shortened lifespan.

The excess death data in the most vaccinated countries is now explainable, and the lack of excess deaths in the non-vaccinated nations like Hungary, Poland, and Romania stands in stark contrast.

Although Professor Buckhaults testified according to Hanlon’s Razor, that we should never attribute malice to what may be due to stupidity, we must remember we are not dealing with stupid adversaries. And abiding by Hanlon’s Razor, although it might preserve one’s job, will not save your life.

Now is the perfect time to congratulate the great Dr. Paul E. Marik for publishing his monumental paper on Repurposed Drugs and Cancer in the Medical Journal Nutrients. Dr. Marik has been on a mission to get the word out on the powerful and life-saving effects of Repurposed Drugs to both prevent and treat cancer, and now is the ideal time for everyone to take notice. You can simply print his Nutrients Article, and no longer can any physician criticize your decision to take these medications to protect or defend you from cancer.

I would submit that now is a more urgent moment than any time before to take advantage of the health-preserving and life-saving effects of these common, safe and easy-to-obtain medications.

Marik’s journal article lists Tier One, Tier Two, and Tier Three medications, in the order of evidence support, and Tier One is what you will want to focus on.

Fenbendazole and Joe Tippens have gotten a lot of recent publicity and for good reason. Joe found a cure from his Small Cell Lung Cancer, and many others claim the same results. These are slowly filtering into Medical Journal Literature proving that these are not merely anecdotal stories, and I might add, much to the chagrin and consternation of Big Pharma who can’t afford you to know this.

Since Fenbendazole is a veterinary drug, and not technically eligible as a human repurposed drug, Dr. Marik wisely confines his discussion to Mebendazole, it’s human counterpart. Mebendazole is one of the most effective anti-cancer drugs and is listed as a Tier One.

Other Tier One drugs include Metformin and Sildenafil, the generic for Viagra. The other drugs in this class will also work, like Tadalafil. Atorvastatin is also listed, and along with Metformin and Mebendazole is part of the 4-drug Care Oncology Clinic Protocol, a highly successful repurposed drug cocktail. What is interesting is that the 4th drug in the COC protocol, Doxycycline, was listed as a Second Tier in Marik’s paper.

Instead, Marik has Itraconazole listed as a First Tier, although this has more adverse effect potential for the average person, and probably should not be taken as a routine preventative agent. However, Cimetidine is listed in its place and is a simple antacid usually so safe that it is available over the counter.

However, other potential safe drugs